Our CEO, David Longo, and CSO, Ziwei Liang, had the great opportunity to talk with Genetic Engineering & Biotechnology News on the exciting opening of our Ordaōs lab space in New York, how it will support our R&D efforts & capabilities in mini-protein design, and how the fusion of AI in biotech is re-shaping the drug discovery process as we know it. Read the article here: https://hubs.li/Q01-R2cl0